David S. Lakomy

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers

Zhen Lü, Weiqun Mao, Hailing Yang et al. · Journal of Clinical Investigation · 2022 · 37 citations · Full text

Systems Biology, Oncology, Triple-negative Breast Cancers +14

Four‐dimensional live imaging of hemodynamics in mammalian embryonic heart with Doppler optical coherence tomography

Shang Wang, David S. Lakomy, Monica D. Garcia et al. · Journal of Biophotonics · 2016 · 24 citations · Full text

Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers

Lilie L. Lin, David S. Lakomy, Elizabeth Y. Chiao et al. · JCO Global Oncology · 2020 · 24 citations · Full text

Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers

David S. Lakomy, Diana L. Urbauer, Shannon N. Westin et al. · Clinical and Translational Radiation Oncology · 2019 · 20 citations · Full text

Parp Inhibitor, Radiation Therapy, Medicine +10

Breast Radiation Therapy–Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing

Bhavana V. Chapman, Diane Liu, Yu Shen et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 11 citations · Full text

Radiation Medicine, Breast Oncology, Multigene Panel +9